生物标志物 生物标志物
Aya Abdallah1, Robert Allen1, Dominik Domanski1
1University of Oxford, Oxford, Oxfordshire, United Kingdom.
Alzheimer's & dementia : the journal of the Alzheimer's Association
|December 24, 2025
概括
这项研究分析了OPTIMA队列中的脑脊液 (CSF),以确定阿尔茨海默病 (AD) 和混合病理的生物标志物. 研究结果突出了活体和死后样本之间的生物标志物度差异,影响了诊断效用.
科学领域:
- 神经科学是一个神经科学.
- 生物标志物发现发现
- 老年学是一门学科.
背景情况:
- 阿尔茨海默病 (AD) 涉及粉样质斑块和神经纤维状结,通常与其他病理共同发生,如勒维体痴呆症 (DLB) 和临主导的与年龄相关的TDP-43脑病变 (LATE).
- 准确的诊断和患者分层需要生物标志物来捕捉这些混合病理,超出已建立的粉样蛋白和蛋白标志物.
- OPTIMA队列为研究神经退行性疾病提供了宝贵的纵向资源.
研究的目的:
- 将高通量脑病理学数据与生物流体测定和蛋白质组学相结合.
- 为了产生新的生物标志物来分层阿尔茨海默病和混合病理的患者.
- 从OPTIMA队列中采集的CSF样本中描述了粉样蛋白,蛋白和神经退行 (ATN) 状态.
主要方法:
- 从OPTIMA队列中332名参与者的基线腰椎脊髓样本的分析,包括纯AD,混合AD+DLB/LATE和健康对照.
- 使用EuroImmun ELISAs对pTau181,t-Tau,Aβ42和Aβ-40度进行量化.
- 包括从一小部分病例中获得的死后腹腔脑脊髓炎数据进行比较分析.
主要成果:
- 来自OPTIMA队列的CSF样本中的ATN状态的表征.
- 死亡后的腹腔脑脊髓与腰部脑脊髓相比,显示出明显更高的pTau181水平.
- 在死后的腹腔脊髓样本中,Aβ-42水平无法检测到.
结论:
- OPTIMA队列对于推进神经退行性疾病的诊断和治疗至关重要.
- 在死后腹腔内核和死前腰部内核之间ATN定义蛋白的度差异可能会限制死后内核作为技术控制的使用.
- 需要进一步的研究来开发可靠的交叉矩阵生物标志物用于混合病理.
相关概念视频
01:20Blood Studies for Cardiovascular System I: Cardiac Biomarkers
749
Cardiac biomarkers are enzymes, proteins, and hormones released into the blood when cardiac cells are injured. They are powerful tools for triaging.
The essential diagnostic tools for detecting myocardial necrosis and monitoring individuals suspected of having acute coronary syndrome (ACS) include:
Troponins
Troponins, particularly cardiac troponins I and T, are the most precise and sensitive markers of myocardial injury. They are detectable within 4-6 hours of myocardial injury and remain...
The essential diagnostic tools for detecting myocardial necrosis and monitoring individuals suspected of having acute coronary syndrome (ACS) include:
Troponins
Troponins, particularly cardiac troponins I and T, are the most precise and sensitive markers of myocardial injury. They are detectable within 4-6 hours of myocardial injury and remain...
749
01:19Blood Studies for Cardiovascular System II: CRP, Hcy, and Cardiac Natriuretic Peptide Markers
516
Cardiac biomarkers are critical in diagnosing, prognosing, and managing cardiovascular diseases. Routine measurement of specific biomarkers such as B-type natriuretic peptide (BNP), C-reactive protein (CRP), and homocysteine (Hcy) is common practice in clinical settings to evaluate heart function and predict cardiovascular events.
These markers indicate stress or strain on the heart muscle:
Natriuretic Peptides (BNP)
Cardiac myocytes produce these hormones in response to ventricular stretching...
These markers indicate stress or strain on the heart muscle:
Natriuretic Peptides (BNP)
Cardiac myocytes produce these hormones in response to ventricular stretching...
516